Lv71
3589 积分 2021-08-04 加入
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial
5小时前
待确认
Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study
1个月前
已完结
Anti-tumor activity of Sanguisorba officinalis L. in non-small cell lung cancer and induced apoptosis via PI3K/Akt/mTOR signaling pathway
5个月前
已完结
Synthesis, in vitro, and in silico studies of morpholine-based thiosemicarbazones as ectonucleotide pyrophosphatase/phosphodiesterase-1 and -3 inhibitors
5个月前
已完结
What Happens in Successful Optimizations? A Survey of 2018–2024 Literature
6个月前
已完结
A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer
6个月前
已关闭
A phase 2 dose expansion study of ZG006, a trispecific T cell engager targeting CD3/DLL3/DLL3, as monotherapy in patients with advanced small cell lung cancer
6个月前
已关闭
Nitroimidazole-Containing [68Ga]Ga-IPM-N001 as a New CAIX-Targeting Radionuclide Tracer
6个月前
已完结
A neomorphic protein interface catalyzes covalent inhibition of RAS G12D aspartic acid in tumors
8个月前
已完结
RIPTACs expand anticancer target space
9个月前
已完结
皖公网安备34019202002308
